Carbamazepine (CBZ) is a pharmaceutical compound recalcitrant to conventional wastewater treatment plants and widely detected in wastewater bodies. In the present study, advanced oxidation processes for carbamazepine removal are investigated, with particular regard to the degradation pathways of carbamazepine by photoelectrocatalysis and conventional photocatalysis. Photoelectrocatalysis was carried out onto TiO₂ meshes obtained by Plasma Electrolytic Oxidation, a well-known technique in the field of industrial surface treatments, in view of an easy scale-up of the process. By photoelectrocatalysis, 99% of carbamazepine was removed in 55 min while only 65% removal was achieved by photolysis. The investigation of the transformation products (TPs) was carried out by means of UPLC-QTOF/MS/MS. Several new TPs were identified and accordingly reaction pathways were proposed. Above 80 min the transformation products disappear, probably forming organic acids of low-molecular weight as final degradation products. The results demonstrated that photoelectrocatalysis onto TiO₂ meshes obtained by plasma electrolytic oxidation is a useful alternative to common advanced oxidation processes as wastewater tertiary treatment aimed at removing compounds of emerging concern.

Diclofenac (DCF) is one of the most detected pharmaceuticals in environmental water matrices and is known to be recalcitrant to conventional wastewater treatment plants. In this study, degradation of DCF was performed in water by photolysis and photocatalysis using a new synthetized photocatalyst based on hydroxyapatite and TiO₂ (HApTi). A degradation of 95% of the target compound was achieved in 24 h by a photocatalytic treatment employing the HApTi catalyst in comparison to only 60% removal by the photolytic process. The investigation of photo-transformation products was performed by means of UPLC-QTOF/MS/MS, and for 14 detected compounds in samples collected during treatment with HApTi, the chemical structure was proposed. The determination of transformation product (TP) toxicity was performed by using different assays: Daphnia magna acute toxicity test, Toxi-ChromoTest, and Lactuca sativa and Solanum lycopersicum germination inhibition test. Overall, the toxicity of the samples obtained from the photocatalytic experiment with HApTi decreased at the end of the treatment, showing the potential applicability of the catalyst for the removal of diclofenac and the detoxification of water matrices.

This study investigated the environmental contamination of groundwater as a consequence of the discharge of treated wastewater into the soil. The investigation focused on a wastewater treatment plant located in an area fractured by karst in the Salento peninsula (Apulia, Italy). Water samples were collected at four sites (raw wastewater, treated wastewater, infiltration trench, and monitoring well), monthly from May to December 2019 (with the exception of August), and were tested for (1) panel of bacteria; (2) enteric viruses; and (3) chemical substances. A gradual reduction in the concentration of bacteria, viruses and contaminants of emerging concern was observed across the profile of soil fissured by karst. All monitored bacteria were absent from the monitoring well, except for Pseudomonas aeruginosa. Pepper mild mottle virus and adenovirus were detected at all sampling sites. Personal care products and X-ray contrast media showed the greatest decrease in concentration from infiltration trench to the monitoring well, while the highest residual concentrations in the monitoring well were found for anticonvulsants (78.5%), antimicrobials (41.3%), and antipsychotic drugs (38.6%). Our results show that parameters provided by current law may not always be sufficient to evaluate the sanitary risk relating to the discharge of treated wastewater to the soil.

Endocrine disrupting compounds (EDCs) in the environment are considered a motif of concern, due to the widespread occurrence and potential adverse ecological and human health effects. The natural estrogen, 17β-estradiol (E2), is frequently detected in receiving water bodies after not being efficiently removed in conventional wastewater treatment plants (WWTPs), promoting a negative impact for both the aquatic ecosystem and human health. In this study, the biodegradation of E2 by Rhodococcus sp. ED55, a bacterial strain isolated from sediments of a discharge point of WWTP in Coloane, Macau, was investigated. Rhodococcus sp. ED55 was able to completely degrade 5 mg/L of E2 in 4 h in a synthetic medium. A similar degradation pattern was observed when the bacterial strain was used in wastewater collected from a WWTP, where a significant improvement in the degradation of the compound occurred. The detection and identification of 17 metabolites was achieved by means of UPLC/ESI/HRMS, which proposed a degradation pathway of E2. The acute test with luminescent marine bacterium Aliivibrio fischeri revealed the elimination of the toxicity of the treated effluent and the standardized yeast estrogenic (S-YES) assay with the recombinant strain of Saccharomyces cerevisiae revealed a decrease in the estrogenic activity of wastewater samples after biodegradation.

The photocatalytic efficiency of an innovative UV-light catalyst consisting of a mesoporous TiO₂ coating on glass fibers was investigated for the degradation of pharmaceuticals (PhACs) in wastewater effluents. Photocatalytic activity of the synthesized material was tested, for the first time, on a secondary wastewater effluent spiked with nine PhACs and the results were compared with the photolysis used as a benchmark treatment. Replicate experiments were performed in a flow reactor equipped with a UV radiation source emitting at 254 nm. Interestingly, the novel photocatalyst led to the increase of the degradation of carbamazepine and trimethoprim (about 2.2 times faster than the photolysis). Several transformation products (TPs) resulting from both the spiked PhACs and the compounds naturally occurring in the secondary wastewater effluent were identified through UPLC-QTOF/MS/MS. Some of them, produced mainly from carbamazepine and trimethoprim, were still present at the end of the photolytic treatment, while they were completely or partially removed by the photocatalytic treatment.

Low‐cost, millimeter‐thick chitosan‐based sponges are engineered with zinc oxide (ZnO) using atomic layer deposition (ALD) to create a multifunctional nanocomposite for the potential application in water remediation and self‐regeneration via solid‐state photocatalysis. Initially, non‐porous chitosan films served as control samples to study the ZnO growth mechanism and its impact on the biopolymer's optical and chemical properties. Subsequently, porous chitosan sponges are engineered to further explore the photocatalyst growth and infiltration into the porous matrix. The characterization of the chitosan/ZnO hybrid material is performed using spectroscopic ellipsometry, X‐ray photoelectron spectroscopy, UV–vis, photoluminescence, and infrared spectroscopy, analyzing the effect of varying the number of ALD cycles, resulting in different ZnO thicknesses in the range of 5–30 nm on the chitosan matrix. A reaction‐limited growth model is found and strong interactions between ZnO and chitosan amino groups significantly enhance the stability in water and impart photocatalytic features. Adsorption tests using Direct Blue 78 dye demonstrated high removal efficiency, with capacities up to 2000 mg g⁻¹, surpassing pristine chitosan sponges, which degrade in water. Electrostatic interactions between dye sulfonate groups and protonated chitosan amino moieties are identified as key to this performance. Preliminary photocatalytic experiments using Naproxen confirms the ZnO‐coated sponges' ability to degrade pollutants, showcasing ALD as a key technology for producing bio‐based, photoactive materials for sustainable water treatment.